Q1-2020 Net Revenues increase 77% over Q4-2019 to $1.2M
15 mai 2020 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., May 15, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), filed its form 10Q for the period ending March 31st, 2020. Within the report,...
Precipio Announces Q1-2020 Corporate Update Call For Shareholders
12 mai 2020 17h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., May 12, 2020 (GLOBE NEWSWIRE) -- Specialty cancer diagnostics company Precipio, Inc. (NASDAQ: PRPO), will be hosting its Quarter1-2020 corporate update call on Tuesday, May 19th at...
Precipio Launches New HemeScreen™ Reagent Rental Program
06 avr. 2020 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., April 06, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has launched its HemeScreen™ Reagent Rental (HSRR) program....
Company Update During the COVID-19 Era
20 mars 2020 09h30 HE
|
Precipio, Inc.
NEW HAVEN, Conn., March 20, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), released today the following letter to shareholders from its CEO, Ilan Danieli. ...
Precipio Completes the Transaction with Poplar Healthcare’s Oncometrix Hematopathology Division
16 mars 2020 09h30 HE
|
Precipio, Inc.
NEW HAVEN, Conn., March 16, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it has completed the non-cash transaction of the transition of...
Precipio achieves impressive initial results of Artificial Intelligence Decision-Support Tool
26 févr. 2020 11h30 HE
|
Precipio, Inc.
Groundbreaking clinical and economic impact to be generated NEW HAVEN, Conn., Feb. 26, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that...
Precipio in advanced discussions with Poplar Healthcare towards a multi-faceted strategic partnership
18 févr. 2020 10h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Feb. 18, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced today that it is in advanced discussions with Poplar Healthcare to...
Precipio Provides Clarification To Amendment No.1 to Form S-1 Filing
28 janv. 2020 07h30 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 28, 2020 (GLOBE NEWSWIRE) -- The management team of Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), would like to provide an explanation on the recent Amendment...
Precipio Provides Clarification To Recent S-1 Filing
15 janv. 2020 07h30 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 15, 2020 (GLOBE NEWSWIRE) -- The management team of Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), would like to provide several clarification points related to...
Precipio announces shareholder update call to kick off 2020
13 janv. 2020 17h00 HE
|
Precipio, Inc.
NEW HAVEN, Conn., Jan. 13, 2020 (GLOBE NEWSWIRE) -- Specialty diagnostics company Precipio, Inc. (NASDAQ: PRPO), announced that on Monday, January 20th at 5pm it will conduct a shareholder update...